Holter monitoring is a non-invasive diagnostic test used to assess and monitor the electrical activity of the heart over an extended period, typically 24 to 48 hours. Named after its inventor, Dr. Norman J. Holter, this portable device records the heart's rhythm continuously, providing a comprehensive analysis of cardiac activity during a person's daily activities. Small electrodes are attached to the chest, and the Holter monitor, a lightweight device, is worn inconspicuously on a belt or shoulder strap. This monitoring method is particularly valuable in detecting irregularities or abnormalities that may not be evident during a brief visit to a healthcare facility. Holter monitoring is commonly employed to diagnose arrhythmias, evaluate the effectiveness of anti-arrhythmic medications, and investigate unexplained symptoms such as palpitations, dizziness, or fainting episodes. The data collected by the Holter monitor allows healthcare professionals to analyze the heart's electrical patterns and make informed decisions about appropriate treatments or interventions. This continuous monitoring plays a crucial role in understanding and managing cardiac conditions, contributing to improved patient care and overall cardiovascular health.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India